{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:22:57Z","timestamp":1780114977090,"version":"3.54.0"},"reference-count":65,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Public Health Reports"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1016\/s0033-3549(04)50158-9","type":"journal-article","created":{"date-parts":[[2004,6,22]],"date-time":"2004-06-22T14:22:16Z","timestamp":1087914136000},"page":"233-251","source":"Crossref","is-referenced-by-count":71,"title":["Effect of race and\/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature"],"prefix":"10.1177","volume":"117","author":[{"given":"Herminia","family":"Palacio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.Anne","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.1016\/S0033-3549(04)50158-9_BIB1","first-page":"853","article-title":"Racial and ethnic differences in access to medical care in managed care plans","volume":"36","author":"Hargraves","year":"2001","journal-title":"Health Serv Res"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB2","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.286.12.1455","article-title":"Racial disparity in influenza vaccination: does managed care narrow the gap between African Americans and whites?","volume":"286","author":"Schneider","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-135-5-200109040-00012","article-title":"Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research","volume":"135","author":"Kressin","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB4","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0272-6386(05)80007-1","article-title":"Reducing racial disparities in transplant activation: whom should we target?","volume":"37","author":"Garg","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB5","unstructured":"Smedley BD, Stith AY, Nelson AR, editors. Institute of Medicine, Board on Health Sciences Policy, Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal treatment: confronting racial and ethnic disparities in health care [cited 2002 Mar 21]. Available from: URL: http:\/\/www.nap.edu\/catalog\/10260.html"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB6","series-title":"Healthy People 2010. 2nd ed. Understanding and improving health and objectives for improving health","author":"Department of Health and Human Services (US)","year":"2000"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB7","unstructured":"Food and Drug Administration (US). Milestones [cited 2001 Nov]. Available from: URL: http:\/\/www.fda.gov\/oashi\/aids\/hiv.html"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB8","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1001\/jama.270.21.2583","article-title":"Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients","volume":"270","author":"Sande","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1996.03540020068031","article-title":"Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society\u2013USA","volume":"276","author":"Carpenter","year":"1996","journal-title":"JAMA"},{"issue":"RR-5","key":"10.1016\/S0033-3549(04)50158-9_BIB10","first-page":"42","article-title":"Kaiser Family Foundation. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. [published erratum appears in MMWR Morb Mortal Wkly Rep 1998 Jul 31;47(29):619]","volume":"47","author":"Department of Health and Human Services","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB11","unstructured":"HIV\/AIDS Treatment Information Service. Guidelines for treatment [cited 2001 Nov]. Available from: URL: http:\/\/www.hivatis.org"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team","volume":"337","author":"Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy","volume":"337","author":"Gulick","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","article-title":"Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1","volume":"4","author":"Komanduri","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB16","series-title":"HIV\/ AIDS Surveillance Report, 1999","first-page":"1","author":"Centers for Disease Control and Prevention (U.S.)","year":"1999"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB17","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","article-title":"Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators","volume":"280","author":"Detels","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB19","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1097\/00002030-199910220-00010","article-title":"Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups","volume":"13","author":"Phillips","year":"1999","journal-title":"Aids"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00002030-200004140-00020","article-title":"Distinguishing efficacy, individual effectiveness, and population effectiveness of therapies","volume":"14","author":"Munoz","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB21","unstructured":"Department of Health and Human Services (US), Henry J. Kaiser Family Foundation. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, 2000. Available from: URL: http:\/\/www.hivatis.org"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB22","unstructured":"Department of Health and Human Services (US), Henry J. Kaiser Family Foundation. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, 2001. Available from: URL: http:\/\/www.hivatis.org"},{"issue":"S-5","key":"10.1016\/S0033-3549(04)50158-9_BIB23","first-page":"1","article-title":"Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus","volume":"38","year":"1989","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-10","key":"10.1016\/S0033-3549(04)50158-9_BIB24","first-page":"1","article-title":"Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus","volume":"40","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-9","key":"10.1016\/S0033-3549(04)50158-9_BIB25","first-page":"14","article-title":"Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex","volume":"42","year":"1993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB26","first-page":"46","article-title":"Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus Infection","volume":"6","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"RR-8","key":"10.1016\/S0033-3549(04)50158-9_BIB27","first-page":"1","article-title":"USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary","volume":"44","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-5","key":"10.1016\/S0033-3549(04)50158-9_BIB28","first-page":"1","article-title":"1997 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS\/IDSA Prevention of Opportunistic Infections Working Group","volume":"46","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-10","key":"10.1016\/S0033-3549(04)50158-9_BIB29","first-page":"1","article-title":"1999 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA)","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB30","first-page":"S32","article-title":"USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS\/IDSA Prevention of Opportunistic Infections Working Group","volume":"21 Suppl 1","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB31","unstructured":"2001 USPHS\/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus."},{"key":"10.1016\/S0033-3549(04)50158-9_BIB32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02599388","article-title":"Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons","volume":"6","author":"Stein","year":"1991","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB33","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2105\/AJPH.84.12.1997","article-title":"Changes in insurance status and access to care for persons with AIDS in the Boston Health Study","volume":"84","author":"Weissman","year":"1994","journal-title":"Am J Public Health"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00042560-199501000-00009","article-title":"Health insurance and use of medical services by men infected with HIV","volume":"8","author":"Katz","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB35","first-page":"543","article-title":"The use of health services by women with HIV infection","volume":"28","author":"Hellinger","year":"1993","journal-title":"Health Serv Res"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/intqhc\/11.4.293","article-title":"The association between primary source of ambulatory care and access to and outcomes of treatment among AIDS patients","volume":"11","author":"McLaughlin","year":"1999","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB37","first-page":"593","article-title":"The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts","volume":"30","author":"Crystal","year":"1995","journal-title":"Health Serv Res"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB38","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0895-4356(94)90115-5","article-title":"Access to therapy in the Multicenter AIDS Cohort Study, 1989\u20131992","volume":"47","author":"Graham","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB39","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM199403173301107","article-title":"Racial differences in the use of drug therapy for HIV disease in an urban community","volume":"330","author":"Moore","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB40","first-page":"123","article-title":"Access and use of medications in HIV disease","volume":"34","author":"Smith","year":"1999","journal-title":"Health Serv Res"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00042560-199803010-00011","article-title":"Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS)","volume":"17","author":"Solomon","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(00)80010-1","article-title":"Drug abuse, methadone treatment, and health services use among injection drug users with AIDS","volume":"60","author":"Sambamoorthi","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00042560-199901010-00013","article-title":"Effect of race on insurance coverage and health service use for HIV-infected gay men","volume":"20","author":"Kass","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-130-12-199906150-00005","article-title":"Translating clinical trial results into practice: the effect of an AIDS clinical trial on prescribed antiretroviral therapy for HIV-infected pregnant women","volume":"130","author":"Turner","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00042560-199812010-00005","article-title":"Factors associated with HIV-infected patients' recognition and use of HIV medications","volume":"19","author":"Jeffe","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00042560-199904150-00010","article-title":"Protease inhibitor use among a community sample of people with HIV disease","volume":"20","author":"Bing","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB47","first-page":"389","article-title":"Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study","volume":"35","author":"Andersen","year":"2000","journal-title":"Health Serv Res"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB48","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1001\/archinte.160.20.3114","article-title":"Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival","volume":"160","author":"Anderson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB49","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00005650-200009000-00005","article-title":"Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women","volume":"38","author":"Turner","year":"2000","journal-title":"Med Care"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/09540129948045","article-title":"Use of protease inhibitors among persons with AIDS in Los Angeles County","volume":"11","author":"Sorvillo","year":"1999","journal-title":"AIDS Care"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB51","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1525-1497.2000.91003.x","article-title":"Housing status and health care service utilization among low-income persons with HIV\/AIDS","volume":"15","author":"Smith","year":"2000","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0895-4356(00)00274-2","article-title":"Therapy naivete in the era of potent antiretroviral therapy","volume":"54","author":"Jacobson","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB53","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.281.24.2305","article-title":"Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study","volume":"281","author":"Shapiro","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00042560-200010010-00005","article-title":"Prevalence and predictors of highly active antiretroviral therapy in patients with HIV infection in the United States","volume":"25","author":"Cunningham","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB55","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.2105\/AJPH.91.9.1474","article-title":"Use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors among Medicaid beneficiaries with AIDS","volume":"91","author":"Sambamoorthi","year":"2001","journal-title":"Am J Public Health"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00042560-200107010-00006","article-title":"Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection","volume":"27","author":"Lucas","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1054-139X(01)00279-8","article-title":"The association of perceived health, clinical status, and initiation of HAART (highly active antiretroviral therapy) in adolescents","volume":"29","author":"Schwarz","year":"2001","journal-title":"J Adolesc Health"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00042560-199812010-00010","article-title":"Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care","volume":"19","author":"Sackoff","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1086\/317555","article-title":"Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995\u20131998","volume":"32","author":"Murphy","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB60","series-title":"HIV\/AIDS Surveillance Report, 2000","first-page":"1","author":"Centers for Disease Control and Prevention","year":"2000"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00005650-198112001-00004","article-title":"Equity of access to medical care: a conceptual and empirical overview","volume":"19","author":"Aday","year":"1981","journal-title":"Med Care"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB62","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2190\/MNCJ-NB8E-M0WA-1FGM","article-title":"Latina and African American women: continuing disparities in health","volume":"23","author":"Lillie-Blanton","year":"1993","journal-title":"Int J Health Serv"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005650-199201000-00002","article-title":"Variation in health service use among HIV-infected patients","volume":"30","author":"Mor","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB64","first-page":"527","article-title":"Correlates of medical service utilization among people with HIV infection","volume":"29","author":"Fleishman","year":"1994","journal-title":"Health Serv Res"},{"key":"10.1016\/S0033-3549(04)50158-9_BIB65","first-page":"180","article-title":"Insurance status among people with AIDS: relationships with sociodemographic characteristics and service use","volume":"30","author":"Fleishman","year":"1993","journal-title":"Inquiry"}],"container-title":["Public Health Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0033354904501589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0033354904501589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T08:13:51Z","timestamp":1497600831000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033354904501589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":65,"aliases":["10.1093\/phr\/117.3.233"],"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["S0033354904501589"],"URL":"https:\/\/doi.org\/10.1016\/s0033-3549(04)50158-9","relation":{},"ISSN":["0033-3549"],"issn-type":[{"value":"0033-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}